The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
In one of the most talked-about lateral moves in recent memory, Bill Savitt has departed Wachtell to join Gibson Dunn, bringing six colleagues with him. Savitt was not merely a senior partner
More
Wall Street indices climbed to record highs as investor sentiment improved significantly following signals that the Strait of Hormuz could reopen to commercial shipping traffic. The Strait of Hormuz is one of
More
A dividend yield of 9.35% from a FTSE-listed company has caught the attention of income-focused investors seeking strong returns in the current market. Such an elevated yield is rare in today’s investment
More
Pfizer has announced an additional $2.5 billion in planned cost savings, extending its sweeping cutback programme through 2029 and bringing its total reduction target to $9.7 billion. The New York-based pharmaceutical giant
More
Women’s health is no longer a narrow policy category on the margins of federal attention, and the consequences for the FemTech industry are significant. FemTech now spans menstrual health, fertility, pregnancy and
More
LinkedIn has long been dismissed as a passive résumé platform, but legal business development coach Steve Fretzin argues it is far more powerful than that. Fretzin, a five-time bestselling author and host
More
St. James’s Place (LSE: STJ) has attracted one of the most bullish price targets on the FTSE 100, with Deutsche Bank forecasting the wealth manager’s shares could surge close to 100%. From
More
The FTSE 250 index continues to attract attention from analysts and retail investors seeking undervalued opportunities in the current UK market environment. Mid-cap stocks listed on the FTSE 250 have historically offered
More
Amgen is pushing deeper into cardiovascular medicine as its cholesterol drug Repatha continues to gain ground following a significant regulatory milestone. The US Food and Drug Administration granted Repatha a label expansion
More
Law schools across the United States operate disciplinary bodies designed to handle violations of institutional honor codes, raising important questions about their function. These bodies, commonly known as honor courts or honor
More